228 related articles for article (PubMed ID: 19759562)
21. Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity.
Malerba A; Boldrin L; Dickson G
Nucleic Acid Ther; 2011 Aug; 21(4):293-8. PubMed ID: 21851223
[TBL] [Abstract][Full Text] [Related]
22. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
[TBL] [Abstract][Full Text] [Related]
23. Comparison between gentamycin and exon skipping treatments to restore ryanodine receptor subtype 2 functions in mdx mouse duodenum myocytes.
Dabertrand F; Mironneau J; Henaff M; Macrez N; Morel JL
Eur J Pharmacol; 2010 Feb; 628(1-3):36-41. PubMed ID: 19944091
[TBL] [Abstract][Full Text] [Related]
24. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
[TBL] [Abstract][Full Text] [Related]
25. The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.
Larochelle N; Oualikene W; Dunant P; Massie B; Karpati G; Nalbantoglu J; Lochmuller H
Biochem Biophys Res Commun; 2002 Apr; 292(3):626-31. PubMed ID: 11922612
[TBL] [Abstract][Full Text] [Related]
26. Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino.
Wu B; Lu P; Cloer C; Shaban M; Grewal S; Milazi S; Shah SN; Moulton HM; Lu QL
Am J Pathol; 2012 Aug; 181(2):392-400. PubMed ID: 22683468
[TBL] [Abstract][Full Text] [Related]
27. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection.
Yanagihara I; Inui K; Dickson G; Turner G; Piper T; Kaneda Y; Okada S
Gene Ther; 1996 Jun; 3(6):549-53. PubMed ID: 8789805
[TBL] [Abstract][Full Text] [Related]
28. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
Kapsa RM; Wong SH; Quigley AF
Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.
Bartoli M; Poupiot J; Goyenvalle A; Perez N; Garcia L; Danos O; Richard I
Gene Ther; 2006 Jan; 13(1):20-8. PubMed ID: 16107863
[TBL] [Abstract][Full Text] [Related]
30. Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.
Moulton HM; Moulton JD
Biochim Biophys Acta; 2010 Dec; 1798(12):2296-303. PubMed ID: 20170628
[TBL] [Abstract][Full Text] [Related]
31. Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.
Jirka SM; Heemskerk H; Tanganyika-de Winter CL; Muilwijk D; Pang KH; de Visser PC; Janson A; Karnaoukh TG; Vermue R; 't Hoen PA; van Deutekom JC; Aguilera B; Aartsma-Rus A
Nucleic Acid Ther; 2014 Feb; 24(1):25-36. PubMed ID: 24320790
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
[TBL] [Abstract][Full Text] [Related]
33. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
34. An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice.
Widrick JJ; Jiang S; Choi SJ; Knuth ST; Morcos PA
Muscle Nerve; 2011 Oct; 44(4):563-70. PubMed ID: 21922468
[TBL] [Abstract][Full Text] [Related]
35. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
[TBL] [Abstract][Full Text] [Related]
37. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
Smith J; Goldsmith C; Ward A; LeDieu R
Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
[TBL] [Abstract][Full Text] [Related]
38. Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation.
Murakami T; Nishi T; Kimura E; Goto T; Maeda Y; Ushio Y; Uchino M; Sunada Y
Muscle Nerve; 2003 Feb; 27(2):237-41. PubMed ID: 12548532
[TBL] [Abstract][Full Text] [Related]
39. One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice.
Wu B; Xiao B; Cloer C; Shaban M; Sali A; Lu P; Li J; Nagaraju K; Xiao X; Lu QL
Mol Ther; 2011 Mar; 19(3):576-83. PubMed ID: 21179007
[TBL] [Abstract][Full Text] [Related]
40. Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.
Yin H; Moulton HM; Seow Y; Boyd C; Boutilier J; Iverson P; Wood MJ
Hum Mol Genet; 2008 Dec; 17(24):3909-18. PubMed ID: 18784278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
